{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:52:56Z","timestamp":1781653976589,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Occupational exposure to chemotherapy poses acute and long-term health risks, including cancers. Personal protective equipment is fundamental to reducing these risks; however, compliance among nurses is still inadequate worldwide. Most existing studies have occurred in industrialized countries, and no published studies have examined compliance with personal protective equipment by oncology nurses in Palestine. This study aimed to assess compliance with personal protective equipment and identify factors influencing compliance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional descriptive design was employed. One hundred oncology nurses (68.5% response rate) from six Palestinian hospitals completed the Hazardous Drug Handling Questionnaire. A Pearson correlation analysis explored relationships between compliance with personal protective equipment and independent variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nurses demonstrated moderate compliance with personal protective equipment (mean\u2009=\u20092.3, standard deviation [SD]\u2009=\u20090.67), with the highest compliance during chemotherapy administration (mean\u2009=\u20092.41, SD\u2009=\u20090.68) and the lowest during disposal (mean\u2009=\u20092.2, SD\u2009=\u20090.90). Influencing factors included insufficient knowledge of chemotherapy exposure risks, perceived barriers to using personal protective equipment, low self-efficacy, moderate perceived exposure risk, and a moderate workplace safety climate. Compliance improved among those with oncology certification (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005) and those who received on-the-job training (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Moderate compliance with personal protective equipment indicates that oncology nurses remain at risk of exposure to chemotherapy. Targeted interventions are required, including continuous education, structured training in safe handling, and developing a supportive workplace culture through monitoring and reinforcement of safety measures. These findings present evidence to guide policymakers and healthcare leaders in strengthening chemotherapy safety standards in Palestinian healthcare centers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-026-14132-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:13:46Z","timestamp":1770120826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nurse compliance with personal protective equipment when handling chemotherapy: a multicenter cross-sectional study in Palestine"],"prefix":"10.1186","volume":"26","author":[{"given":"Nader","family":"Lama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Saca-Hazboun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"1","key":"14132_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/2165079916662660","volume":"65","author":"CU Graeve","year":"2017","unstructured":"Graeve CU, McGovern PM, Alexander B, Church T, Ryan A, Polovich M. Occupational exposure to antineoplastic agents: an analysis of Health care workers and their environments. Workplace Health Saf. 2017, Jan;65(1):9\u201320.","journal-title":"Workplace Health Saf"},{"key":"14132_CR2","doi-asserted-by":"crossref","unstructured":"Menonna-Quinn D, Polovich M, Marshall B. Personal protective equipment: evaluating usage among inpatient and Outpatient oncology nurses. Clin J Oncol Nurs. 2019, June, 1;23(3).","DOI":"10.1188\/19.CJON.462"},{"key":"14132_CR3","unstructured":"American Cancer Society. Chemotherapy: what it is, how it helps [Internet]. 2016. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/cancer-control\/en\/booklets-flyers\/chemotherapy-what-it-is-how-it-helps.pdf."},{"issue":"2","key":"14132_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1570-0232(03)00100-4","volume":"789","author":"R Turci","year":"2003","unstructured":"Turci R, Sottani C, Spagnoli G, Minoia C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chromatogr B. 2003, June;789(2):169\u2013209.","journal-title":"J Chromatogr B"},{"issue":"3","key":"14132_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1188\/16.ONF.43-03AP","volume":"43","author":"A Callahan","year":"2016","unstructured":"Callahan A, Ames N, Manning ML, Touchton-Leonard K, Yang L, Wallen G. Factors influencing nurses\u2019 use of Hazardous Drug Safe-handling Precautions. Oncol Nurs Forum. 2016, May, 1;43(3):342\u2013349.","journal-title":"Oncol Nurs Forum"},{"issue":"11","key":"14132_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1080\/15459624.2014.916809","volume":"11","author":"JM Boiano","year":"2014","unstructured":"Boiano JM, Steege AL, Sweeney MH. Adherence to Safe handling guidelines by Health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014, Nov, 2;11(11):728\u2013740.","journal-title":"J Occup Environ Hyg"},{"issue":"2","key":"14132_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4236\/ojn.2012.22015","volume":"2","author":"N Khan","year":"2012","unstructured":"Khan N, Khowaja KZA, Ali TS. Assessment of knowledge, skill and attitude of oncology nurses in chemotherapy administration in tertiary hospital Pakistan. Open J Nurs. 2012;2(2):97\u2013103.","journal-title":"Open J Nurs"},{"issue":"1","key":"14132_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1188\/17.CJON.73-78","volume":"21","author":"R Crickman","year":"2017","unstructured":"Crickman R. Chemotherapy Safe handling: limiting Nursing exposure with a Hazardous Drug control program. Clin J Oncol Nurs. 2017, Feb, 1;21(1):73\u201378.","journal-title":"Clin J Oncol Nurs"},{"issue":"7","key":"14132_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/15459624.2017.1285496","volume":"14","author":"DM DeJoy","year":"2017","unstructured":"DeJoy DM, Smith TD, Woldu H, Dyal MA, Steege AL, Boiano JM. Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses. J Occup Environ Hyg. 2017, July, 3;14(7):485\u2013493.","journal-title":"J Occup Environ Hyg"},{"issue":"4","key":"14132_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1470-2045(03)01033-7","volume":"4","author":"K Deniz","year":"2003","unstructured":"Deniz K, O\u2019Mahony S, Ross G, Purushotham A. Breast cancer in women after treatment for Hodgkin\u2019s disease. Lancet Oncol. 2003, Apr;4(4):207\u2013214.","journal-title":"Lancet Oncol"},{"issue":"18","key":"14132_CR11","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2003.07.160","volume":"21","author":"A Josting","year":"2003","unstructured":"Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, et al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin\u2019s disease: a report from the German Hodgkin\u2019s lymphoma study group. J Clin Oncol. 2003, Sept, 15;21(18):3440\u20133446.","journal-title":"J Clin Oncol"},{"issue":"4","key":"14132_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1188\/16.CJON.20-04AP","volume":"20","author":"S Eisenberg","year":"2016","unstructured":"Eisenberg S. A call to action for Hazardous Drug safety: where We have been and Where We are Now. Clin J Oncol Nurs. 2016, Aug, 1;20(4):377\u2013384.","journal-title":"Clin J Oncol Nurs"},{"key":"14132_CR13","unstructured":"Oncology Nursing Society. Ensuring healthcare worker safety when handling hazardous drugs [Internet]. 2016. Available from: https:\/\/www.ons.org\/network-advocacy\/position-statements\/ensuring-healthcare-worker-safety-when-handling-hazardous-drugs."},{"issue":"4","key":"14132_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1188\/06.CJON.473-477","volume":"10","author":"J Gambrell","year":"2006","unstructured":"Gambrell J, Moore S. Assessing workplace compliance with handling of antineoplastic agents. Clin J Oncol Nurs. 2006, Aug, 1;10(4):473\u2013477.","journal-title":"Clin J Oncol Nurs"},{"issue":"4","key":"14132_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1188\/03.ONF.575-581","volume":"30","author":"S Martin","year":"2003","unstructured":"Martin S, Larson E. Chemotherapy-handling practices of Outpatient and office-based oncology nurses. Oncol Nurs Forum. 2003, Jan, 1;30(4):575\u2013581.","journal-title":"Oncol Nurs Forum"},{"issue":"10","key":"14132_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/JOM.0b013e3181f73ae6","volume":"52","author":"MA McDiarmid","year":"2010","unstructured":"McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010, Oct;52(10):1028\u20131034.","journal-title":"J Occup Environ Med"},{"key":"14132_CR17","doi-asserted-by":"crossref","unstructured":"Polovich M, Clark PC. Factors influencing oncology nurses\u2019 use of Hazardous Drug Safe-handling Precautions. Oncol Nurs Forum. 2012, May, 1;39(3):E299\u2013309.","DOI":"10.1188\/12.ONF.E299-E309"},{"key":"14132_CR18","doi-asserted-by":"crossref","unstructured":"Chiao CH, Lu Z J, Lee SH. Nurses\u2019 experiences in safe handling of chemotherapeutic agents: the Taiwan case. Cancer Nurs. 2016, Sept;39(5):E29\u201338.","DOI":"10.1097\/NCC.0000000000000314"},{"issue":"9","key":"14132_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/bmjqs-2011-000178","volume":"21","author":"CR Friese","year":"2012","unstructured":"Friese CR, Himes-Ferris L, Frasier MN, McCullagh MC, Griggs JJ. Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Qual Saf. 2012, Sept;21(9):753\u2013759.","journal-title":"BMJ Qual Saf"},{"key":"14132_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DHPS.S289025","volume":"13","author":"S Asefa","year":"2021","unstructured":"Asefa S, Aga F, Dinegde NG, Demie TG. Knowledge and practices on the Safe handling of cytotoxic drugs among oncology nurses working at tertiary teaching hospitals in Addis Ababa, Ethiopia. Drug Healthc Patient Saf. 2021, Mar;13:71\u201380.","journal-title":"Drug Healthc Patient Saf"},{"key":"14132_CR21","doi-asserted-by":"crossref","unstructured":"Halahleh K, Gale RP. Cancer care in the Palestinian territories. Lancet Oncol. 2018, July;19(7):e359\u201364.","DOI":"10.1016\/S1470-2045(18)30323-1"},{"issue":"3","key":"14132_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2165079920959991","volume":"69","author":"AS Loai","year":"2021","unstructured":"Loai AS, Subih M, Bani Salameh A, Malak M. Predictors of chemotherapy Safe-handling Precautions and knowledge among a sample of Jordanian oncology nurses: a model-building approach. Workplace Health Saf. 2021, Mar;69(3):115\u2013123.","journal-title":"Workplace Health Saf"},{"issue":"1","key":"14132_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5388\/aon.2021.21.1.42","volume":"21","author":"H Lee","year":"2021","unstructured":"Lee H, Song JE, Ahn JA, Boo S. Factors influencing compliance with Safe handling of antineoplastic agents among clinical nurses. Asian Oncol Nurs. 2021;21(1):42.","journal-title":"Asian Oncol Nurs"},{"key":"14132_CR24","volume-title":"Nurses\u2019 use of Hazardous Drug Safe handling Precautions","author":"M Polovich","year":"2010","unstructured":"Polovich M, Clark P. Nurses\u2019 use of Hazardous Drug Safe handling Precautions. Georgia State University; 2010."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14132-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14132-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14132-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:02:24Z","timestamp":1781650944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14132-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14132"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14132-x","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki and the requirements of the General Data Protection Regulation (GDPR). Ethical approval was granted from the Bethlehem University review board (Reference number: 17\/201\/2023) on January 18, 2023 (see Additional File 3). Eligible nurses received written informed consent describing the study aims, duration, and potential risks. All consent forms were kept separate from the questionnaires to ensure confidentiality. Participation was voluntary, and nurses could withdraw at any time before questionnaire submission. No personal identifiers were collected. Participants were assigned numerical codes for analysis purposes only. Completed questionnaires were returned in sealed envelopes and securely stored.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}